Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 396

1.

Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.

Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):685-91. doi: 10.1089/aid.2009.0222.

2.

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.

Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):37-46. doi: 10.1097/QAI.0b013e31819ff102.

3.

Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa.

Mekuria LA, Prins JM, Yalew AW, Sprangers MA, Nieuwkerk PT.

AIDS Care. 2017 Apr;29(4):428-435. doi: 10.1080/09540121.2016.1234681. Epub 2016 Oct 4.

PMID:
27701908
4.

HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.

Sumari-de Boer IM, Sprangers MA, Prins JM, Nieuwkerk PT.

AIDS Behav. 2012 Aug;16(6):1681-9. doi: 10.1007/s10461-011-0112-y.

5.

Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.

Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R.

J Manag Care Spec Pharm. 2014 Aug;20(8):844-50.

6.

Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa.

Mekuria LA, Sprangers MA, Prins JM, Yalew AW, Nieuwkerk PT.

AIDS Care. 2015;27(8):934-45. doi: 10.1080/09540121.2015.1020748. Epub 2015 Mar 18.

PMID:
25782603
7.

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.

Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, Hirschel B, Bernasconi E, Rickenbach M, Günthard HF, Bucher HC; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):197-203. doi: 10.1097/QAI.0b013e3181ca48bf.

PMID:
20035231
8.
9.

Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.

Dworkin MS, Douglas GW, Sabitha Rani GP, Chakraborty A.

Int J STD AIDS. 2016 Mar;27(3):186-95. doi: 10.1177/0956462415578545. Epub 2015 Mar 22.

PMID:
25801316
10.

High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors.

Kim MH, Mazenga AC, Yu X, Ahmed S, Paul ME, Kazembe PN, Abrams EJ.

J Int AIDS Soc. 2017 Mar 30;20(1):1-12. doi: 10.7448/IAS.20.1.21437.

PMID:
28406275
11.

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):281-8.

PMID:
14600572
12.
13.
14.

Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study.

Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, Kestelyn E, Vyankandondera J, Pool R, Ruhirimbura J, Kanakuze C, Reiss P, Geelen S, van de Wijgert J, Boer KR.

PLoS One. 2013;8(4):e60073. doi: 10.1371/journal.pone.0060073. Epub 2013 Apr 3.

15.

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Grierson J, Koelmeyer RL, Smith A, Pitts M.

HIV Med. 2011 Oct;12(9):562-9. doi: 10.1111/j.1468-1293.2011.00928.x. Epub 2011 May 9.

16.

Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.

Wester CW, Thomas AM, Bussmann H, Moyo S, Makhema JM, Gaolathe T, Novitsky V, Essex M, deGruttola V, Marlink RG.

AIDS. 2010 Jan;24 Suppl 1:S27-36. doi: 10.1097/01.aids.0000366080.91192.55.

18.

Patterns of adherence to scheduling and dietary instructions among patients on antiretroviral therapy in Pretoria, South Africa.

Adefolalu AO, Nkosi ZZ, Olorunju SA.

Trans R Soc Trop Med Hyg. 2014 Sep;108(9):582-8. doi: 10.1093/trstmh/tru116. Epub 2014 Aug 5.

PMID:
25096293
19.

Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.

Been SK, van de Vijver DA, Nieuwkerk PT, Brito I, Stutterheim SE, Bos AE, Wolfers ME, Pogány K, Verbon A.

PLoS One. 2016 Oct 5;11(10):e0162800. doi: 10.1371/journal.pone.0162800. eCollection 2016.

20.

Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV.

Wilson IB, Laws MB, Safren SA, Lee Y, Lu M, Coady W, Skolnik PR, Rogers WH.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):338-47. doi: 10.1097/QAI.0b013e3181c7a245.

Supplemental Content

Support Center